Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Modulation of a specific prostanoid synthase or receptor provides therapeutic alternatives to non-steroidal anti-inflammatory drugs (NSAIDs) for treating cyclooxygenase-2 (COX-2 or PTGS2)-governed pathological conditions. Among the COX-2 downstream signaling pathways, the prostaglandin E2 (PGE2) receptor EP2 subtype (PTGER2) is emerging as a crucial mediator of many physiological and pathological events. Genetic ablation strategies and recent advances in chemical biology provide tools for a better understanding of EP2 signaling. In the brain, the EP2 receptor modulates some beneficial effects including neuroprotection in acute models of excitotoxicity, neuroplasticity, and spatial learning via cAMP/PKA signaling. Conversely, EP2 activation accentuates chronic inflammation mainly through the cAMP/Epac pathway, likely contributing to delayed neurotoxicity. EP2 receptor activation also engages β-arrestin in a G protein-independent pathway that promotes tumor cell growth and migration. Understanding the conditions under which multiple EP2 signaling pathways are engaged might suggest novel therapeutic strategies targeting this key inflammatory prostaglandin receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells
Subbaramaiah, K., Hudis, C. A., Chang, S.-H., Hla, T., & Dannenberg, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705409200 · Cited by 96 · cited 1×
“For example, aromatase-dependent estrogen synthesis is associated with hormone-dependent breast carcinogenesis, and EP2 can regulate cytochrome P450 aromatase via the cAMP/PKA/ CREB pathway [71].”
RetractedDonnini, S., Finetti, F., Solito, R., Terzuoli, E., Sacchetti, A., Morbidelli, L., Patrignani, P., & Ziche, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7581com · Cited by 96 · cited 3×
“In the periphery, EP2 activation can improve survival of gastrointestinal epithelial cells after radiation injury, via transactivation of EGFR and enhancement of PI3K/Akt signaling cascade, which suppresses translocation of the proapoptotic protein bax to the mitochondrial membrane, thus abrogating a prominent apoptot…”
RetractedImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 2×
“COX-2 and its derived prostanoids have attracted substantial attention for their possible roles in tumor progression and angiogenesis [53-57].”
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312 · cited 2×
“As a major inflammatory mediator derived from COX-2, PGE2 via EP2 can induce many pro-inflammatory mediators including cytokines, chemokines, iNOS, and COX-2 itself, which then facilitate cell proliferation, cell survival, angiogenesis, invasion, and metastasis [64, 74].”
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052 · cited 1×
“It is now clear that microglia are major cellular culprits of EP2-mediated chronic inflammation and neuronal damage [82], because only glia, particularly microglia, express TLR4 [87], which is activated by LPS or proteins released from nearby injured neurons to initiate an innate immune response via CD14 [88].”
Saijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., & Koki, A. T. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b · Cited by 862
Regulation of AMPA receptors during synaptic plasticity
Song, I., & Huganir, R. L. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02270-1 · Cited by 777
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660 · cited 1×
“Sustained inhibition of COX-2 can exert beneficial effects in neurodegenerative disease models such as Alzheimer's disease (AD) [93], Parkinson's disease (PD) [94], and amyotrophic lateral sclerosis (ALS) [95], and is accompanied by reduced number of activated microglia [96], suggesting that downstream prostanoid sign…”
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
GlyR α3: An Essential Target for Spinal PGE 2 -Mediated Inflammatory Pain Sensitization
Harvey, R. J., Depner, U. B., Wässle, H., Ahmadi, S., Heindl, C., Reinold, H., Smart, T. G., Harvey, K., Schütz, B., Abo-Salem, O. M., et al. (2004) · Science · doi:10.1126/science.1094925 · Cited by 598 · cited 1×
“It appears that PGE2 mediates inflammatory pain sensitization induced by spinal PGE2 injection or peripheral inflammation via inhibiting the glycine receptor α3 subtype, and thus blocking inhibitory glycinergic neurotransmission [50].”
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587 · cited 2×
“In addition, PGE2 signaling through EP2 can in turn boost expression of COX-2 and vascular endothelial growth factor (VEGF) in polyp tissues [61].”
Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y., & Narumiya, S. (2009) · Nature Medicine · doi:10.1038/nm.1968 · Cited by 566 · cited 1×
“Like EP4, EP2 promotes T helper (Th1) cell differentiation also through PI3K/Akt rather than its conventional cAMP signaling [21].”
Abramovitz, M., Adam, M., Boie, Y., Carrière, M.-C., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N. M., et al. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00164-x · Cited by 557 · cited 1×
“However, butaprost is only about 18-fold selective for EP2 over EP3 in binding studies [32]; CAY10399 and ONO-AE1-259 are highly EP2 selective but have a prostanoid-like structure; CP-533536 is only about 64-fold selective over the EP4 receptor [33]; compound 9 is quite selective against other PGE2 receptors but less…”
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase
Trebino, C. E., Stock, J. L., Gibbons, C. P., Naiman, B. M., Wachtmann, T. S., Umland, J. P., Pandher, K., Lapointe, J.-M., Saha, S., Roach, M. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332766100 · Cited by 552 · cited 2×
“Often inflammation resolves rather quickly, but chronic inflammation appears to contribute to the pathophysiology of many chronic conditions including rheumatoid arthritis, pain, cancer and neurological disorders [39, 40, 42].”
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Samuelsson, B., Morgenstern, R., & Jakobsson, P.-J. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 538
Epac proteins: multi-purpose cAMP targets
Bos, J. L. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.10.002 · Cited by 532 · cited 3×
“In the past decade, Epac has emerged as an alternative cAMP sensor [6].”
InfluentialBoniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479 · cited 1×
“PGE2, together with IL-1β and IL-23, facilitates Th17 cell differentiation and cytokine expression mainly through EP2 and cAMP signaling; whereas PGE2 acts on the EP4 receptor to downregulate IFN-γ and IL-10 produced in Th17 cells [45].”
Hizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 465
Iadecola, C., Niwa, K., Nogawa, S., Zhao, X., Nagayama, M., Araki, E., Morham, S., & Ross, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1294 · Cited by 411
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391 · cited 2×
“Mice lacking EP2 receptors (EP2−/−) have been independently developed in at least three groups [29-31].”
Neuroprotective Function of the PGE2EP2 Receptor in Cerebral Ischemia
McCullough, L., Wu, L., Haughey, N., Liang, X., Hand, T., Wang, Q., Breyer, R. M., & Andreasson, K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4485-03.2004 · Cited by 361 · cited 6×
“EP2 activation by the selective agonist butaprost, or EP2 allosteric potentiators, can protect neurons from N-methyl-Daspartate (NMDA) receptor-mediated excitotoxicity and oxygen-glucose deprivation(OGD) induced-anoxia in cultured neurons and hippocampal organotypic slices [16, 35, 105, 106].”
InfluentialAronoff, D. M., Canetti, C., & Peters-Golden, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.559 · Cited by 360
Drachman, D. B., Frank, K., Dykes‐Hoberg, M., Teismann, P., Almer, G., Przedborski, S., & Rothstein, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10374 · Cited by 307 · cited 2×
“Drachman DB, et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.”
Prostaglandins and chronic inflammation
Aoki, T., & Narumiya, S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.004 · Cited by 291 · cited 2×
“Often inflammation resolves rather quickly, but chronic inflammation appears to contribute to the pathophysiology of many chronic conditions including rheumatoid arthritis, pain, cancer and neurological disorders [39, 40, 42].”
Sheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8138 · Cited by 284
Lee, K., Kang, B., Lee, H., Son, S., Hwang, S., Kim, D., Park, J., & Cho, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03441.x · Cited by 253 · cited 1×
“Certain inflammatory cytokines induce COX-2 expression via an NF-κB pathway [38], which in turn synthesizes PGE2, a secondary mediator of inflammation that promotes local vasodilation and attraction and activation of neutrophils, macrophages and mast cells during acute inflammation [39, 40].”
Yang, L., Yamagata, N., Yadav, R., Brandon, S., Courtney, R. L., Morrow, J. D., Shyr, Y., Boothby, M., Joyce, S., Carbone, D. P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16492 · Cited by 250 · cited 1×
“dendritic cell differentiation and function and cancer-associated immunodeficiency [62].”
Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249 · cited 2×
“Mice lacking EP2 receptors (EP2−/−) have been independently developed in at least three groups [29-31].”
Cyclic nucleotide analogs as probes of signaling pathways
Poppe, H., Rybalkin, S. D., Rehmann, H., Hinds, T. R., Tang, X.-B., Christensen, A. E., Schwede, F., Genieser, H.-G., Bos, J. L., Doskeland, S. O., et al. (2008) · Nature Methods · doi:10.1038/nmeth0408-277 · Cited by 234 · cited 1×
“The differential regulation of PKA and Epac by cAMP could be related to the gradient of cytoplasmic cAMP because cAMP has a lower affinity for Epac than for PKA [17], (i.”
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Grosser, T., Yu, Y., & FitzGerald, G. A. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-011209-153129 · Cited by 232 · cited 2×
“However, the deleterious cardiovascular and cerebrovascular side effects from sustained inhibition of COX-2 point to beneficial actions of some COX-2 downstream prostanoid signaling [3].”
Hucho, T. B., Dina, O. A., & Levine, J. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0285-05.2005 · Cited by 231
Liang, X., Wang, Q., Hand, T., Wu, L., Breyer, R. M., Montine, T. J., & Andreasson, K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3591-05.2005 · Cited by 226 · cited 1×
“Genetic ablation of EP2 reduces oxidative stress in the APPSwe-PS1ΔE9 mouse model of familial AD, accompanied by reduced levels of Aβ peptides and APP C-terminal fragments, possibly via regulating β-secretase [102].”
Emerging roles of PGE2 receptors in models of neurological disease
Andreasson, K. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.003 · Cited by 219
Zhang, J., & Rivest, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00682.x · Cited by 216 · cited 1×
“EP2 expression is substantially induced during systemic inflammation in models of innate immunity produced by LPS, IL-1β or turpentine [80].”
Honda, T., Segi-Nishida, E., Miyachi, Y., & Narumiya, S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051310 · Cited by 208 · cited 2×
“Experiments with mice deficient in each of the four subtypes of the PGE2 receptor demonstrate that PGE2/EP2 or EP4 together with PGI2/IP signaling play crucial roles in the development of collagen-induced arthritis (CIA) [43].”
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Reinold, H., Ahmadi, S., Depner, U. B., Layh, B., Heindl, C., Hamza, M., Pahl, A., Brune, K., Narumiya, S., Müller, U., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23618 · Cited by 202 · cited 1×
“In a model of peripheral inflammation, EP2−/− mice show normal early peripheral hyperalgesia, but lack the chronic hyperalgesic phase of spinal origin that might be mediated by dorsal horn nociceptive neurons [49].”
Fetal immunization of baboons induces a fetal-specific antibody response
Watts, A. M., Stanley, J. R., Shearer, M. H., Hefty, P. S., & Kennedy, R. C. (1999) · Nature Medicine · doi:10.1038/7426 · Cited by 193
Sang, N., Zhang, J., Marcheselli, V., Bazan, N. G., & Chen, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2392-05.2005 · Cited by 192 · cited 1×
“However, presynaptic EP2 receptors might also be involved in synaptic transmission if postsynaptic PGE2 acts as a retrograde messenger [26].”
An EP2 receptor-selective prostaglandin E2agonist induces bone healing
Paralkar, V. M., Borovecki, F., Ke, H. Z., Cameron, K. O., Lefker, B., Grasser, W. A., Owen, T. A., Li, M., DaSilva-Jardine, P., Zhou, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1037343100 · Cited by 183
Yang, Y., Shu, X., Liu, D., Shang, Y., Wu, Y., Pei, L., Xu, X., Tian, Q., Zhang, J., Qian, K., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.003 · Cited by 181
Enhancement of colon carcinogenesis by prostaglandin E2 administration
Kawamori, T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg033 · Cited by 179
Serrano, G. E., Lelutiu, N., Rojas, A., Cochi, S., Shaw, R., Makinson, C. D., Wang, D., FitzGerald, G. A., & Dingledine, R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3922-11.2011 · Cited by 168 · cited 2×
“For example, intracerebroventricular administration of EP2 agonist– butaprost immediately after termination of pilocarpine-induced status epilepticus affords moderate neuroprotection in a rat [2].”
Self-citationTessner, T. G., Muhale, F., Riehl, T. E., Anant, S., & Stenson, W. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422218 · Cited by 167
Jiang, J., Quan, Y., Ganesh, T., Pouliot, W. A., Dudek, F. E., & Dingledine, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218498110 · Cited by 165
Self-citationaf Forselles, K., Root, J., Clarke, T., Davey, D., Aughton, K., Dack, K., & Pullen, N. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01495.x · Cited by 161
Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling
Medeiros, A. I., Serezani, C. H., Lee, S. P., & Peters-Golden, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082058 · Cited by 159 · cited 1×
“dampening innate antibacterial responses, which would be expected to exacerbate inflammation [48].”
Sheibanie, A. F., Khayrullina, T., Safadi, F. F., & Ganea, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22794 · Cited by 151
Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent
Montine, T. J., Milatovic, D., Gupta, R. C., Valyi‐Nagy, T., Morrow, J. D., & Breyer, R. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01157.x · Cited by 133
Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., BREYER, R. M., & Lin, P. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209694 · Cited by 133
Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
Liu, D., Wu, L., Breyer, R., Mattson, M. P., & Andreasson, K. (2005) · Annals of Neurology · doi:10.1002/ana.20461 · Cited by 129
Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration
Murray, A., & Shewan, D. A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.05.006 · Cited by 127
PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis
Bilak, M., Wu, L., Wang, Q., Haughey, N., Conant, K., St. Hillaire, C., & Andreasson, K. (2004) · Annals of Neurology · doi:10.1002/ana.20179 · Cited by 126
Ster, J., de Bock, F., Guérineau, N. C., Janossy, A., Barrère‐Lemaire, S., Bos, J. L., Bockaert, J., & Fagni, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611031104 · Cited by 124 · cited 1×
“In the central nervous system (CNS), Epac can regulate learning and memory [7], axon growth, guidance and regeneration [8], neuronal differentiation [9], neuronal excitability [10], learning and social Interactions [11], brain oxidative stress [12], neuronal apoptosis [13], and inflammatory hyperalgesia [14, 15].”
Jiang, J., Ganesh, T., Du, Y., Quan, Y., Serrano, G. E., Qui, M., Speigel, I. A., Rojas, A., Lelutiu, N. B., & Dingledine, R. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120195109 · Cited by 122
Self-citationVarvel, N. H., Bhaskar, K., Kounnas, M. Z., Wagner, S. L., Yang, Y., Lamb, B. T., & Herrup, K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39716 · Cited by 121 · cited 1×
“Sustained inhibition of COX-2 can exert beneficial effects in neurodegenerative disease models such as Alzheimer's disease (AD) [93], Parkinson's disease (PD) [94], and amyotrophic lateral sclerosis (ALS) [95], and is accompanied by reduced number of activated microglia [96], suggesting that downstream prostanoid sign…”
Walker, W., & Rotondo, D. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01810.x · Cited by 121
Shie, F., BREYER, R. M., & Montine, T. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62336-x · Cited by 120
Liang, X., Wang, Q., Shi, J., Lokteva, L., Breyer, R. M., Montine, T. J., & Andreasson, K. (2008) · Annals of Neurology · doi:10.1002/ana.21437 · Cited by 119
Banu, S. K., Lee, J., Speights, V. O., Starzinski-Powitz, A., & Arosh, J. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0017 · Cited by 116
Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC
Li, R., Mouillesseaux, K. P., Montoya, D., Cruz, D., Gharavi, N., Dun, M., Koroniak, L., & Berliner, J. A. (2006) · Circulation Research · doi:10.1161/01.res.0000207394.39249.fc · Cited by 113 · cited 12×
“Cheon H, et al. Prostaglandin E2 augments IL-10 signaling and function.”
InfluentialMicroglial EP2 is critical to neurotoxicity from activated cerebral innate immunity
Shie, F., Montine, K. S., Breyer, R. M., & Montine, T. J. (2005) · Glia · doi:10.1002/glia.20220 · Cited by 110 · cited 4×
“Interestingly, EP2 receptor ablation enhances microglia-mediated phagocytosis of Aβ and totally eliminates Aβ-triggered paracrine neurotoxicity mediated by microglia [82, 99].”
InfluentialSung, Y. M., He, G., & Fischer, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1015 · Cited by 110
Jin, J., Shie, F.-S., Liu, J., Wang, Y., Davis, J., Schantz, A. M., Montine, K. S., Montine, T. J., & Zhang, J. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-2 · Cited by 109 · cited 3×
“As the resident macrophage of the brain, microglia are the major executor of innate immunity in the CNS and their activities are highly regulated by PGE2/EP2 signaling [52, 84-86].”
The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia
Chang, S.-H., Ai, Y., BREYER, R. M., Lane, T. F., & Hla, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0129 · Cited by 109
Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors
Kabashima, K., Nagamachi, M., Honda, T., Nishigori, C., Miyachi, Y., TOKURA, Y., & Narumiya, S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700491 · Cited by 109 · cited 1×
“In addition, PGE2 signaling via EP2 or EP4 receptors can regulate UV-induced acute skin inflammation by increasing skin microenviromental blood flow [46].”
Li, M., Ke, H. Z., Qi, H., Healy, D. R., Li, Y., Crawford, D. T., Paralkar, V. M., Owen, T. A., Cameron, K. O., Lefker, B. A., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.2033 · Cited by 109
Hösl, K. M., Reinold, H., Harvey, R. J., Müller, U., Narumiya, S., & Zeilhofer, H. U. (2006) · Pain · doi:10.1016/j.pain.2006.06.011 · Cited by 106 · cited 1×
“However, this EP2 receptor-dependent inhibition of glycinergic neurotransmission does not contribute to pain sensitization in the chronic constriction injury model of neuropathic pain and chemical-induced pain [51].”
Jiang, J., & Dingledine, R. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200444 · Cited by 106
Self-citationEP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia
Quan, Y., Jiang, J., & Dingledine, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455816 · Cited by 105 · cited 7×
“The inflammation regulated by microglial EP2 appears to be mediated largely via cAMP/Epac signaling (Figure 2) [86].”
InfluentialSelf-citationGalandrin, S., Oligny-Longpré, G., Bonin, H., Ogawa, K., Galès, C., & Bouvier, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043893 · Cited by 104
Yamane, H., Sugimoto, Y., Tanaka, S., & Ichikawa, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3779 · Cited by 104
Shi, G.-X., Rehmann, H., & Andres, D. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00332-06 · Cited by 100
Prostaglandin E2 Augments IL-10 Signaling and Function
Cheon, H., Rho, Y. H., Choi, S. J., Lee, Y. H., Song, G. G., Sohn, J., Won, N. H., & Ji, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1092 · Cited by 100 · cited 1×
“Thus PGE2 acts as an immune modulator rather than a simple pro-inflammatory molecule [41].”
Therapeutic Targets in Prostaglandin E2 Signaling for Neurologic Disease
Cimino, P., Keene, C., Breyer, R., Montine, K., & Montine, T. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132915 · Cited by 99
Wang, C., Gu, Y., Li, G., & Huang, L.-Y. M. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.135616 · Cited by 97
Akaogi, J., Yamada, H., Kuroda, Y., Nacionales, D. C., Reeves, W. H., & Satoh, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203627 · Cited by 90
Eijkelkamp, N., Wang, H., Garza-Carbajal, A., Willemen, H. L. D. M., Zwartkruis, F. J., Wood, J. N., Dantzer, R., Kelley, K. W., Heijnen, C. J., & Kavelaars, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3142-10.2010 · Cited by 88 · cited 2×
“In the central nervous system (CNS), Epac can regulate learning and memory [7], axon growth, guidance and regeneration [8], neuronal differentiation [9], neuronal excitability [10], learning and social Interactions [11], brain oxidative stress [12], neuronal apoptosis [13], and inflammatory hyperalgesia [14, 15].”
Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor
Jiang, J., Ganesh, T., Du, Y., Thepchatri, P., Rojas, A., Lewis, I., Kurtkaya, S., Li, L., Qui, M., Serrano, G. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909310107 · Cited by 88 · cited 4×
“Emerging allosteric potentiators and antagonists have already proved valuable tools to explore the roles of EP2 receptor under normal or disease conditions [35-37, 64, 86, 104]; however, development of EP2-targeted drugs for therapeutic use will require careful attention to temporal and probably spatial extent of drug…”
InfluentialSelf-citationEpac signaling is required for hippocampus-dependent memory retrieval
Ouyang, M., Zhang, L., Zhu, J., Schwede, F., & THOMAS, S. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804172105 · Cited by 84
Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer's disease
McPhee, I., Gibson, L. C. D., Kewney, J., Darroch, C., Stevens, P., Spinks, D., Cooreman, A., & MacKenzie, S. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051330 · Cited by 82
Differential Roles of Epac in Regulating Cell Death in Neuronal and Myocardial Cells
Suzuki, S., Yokoyama, U., Abe, T., Kiyonari, H., Yamashita, N., Kato, Y., Kurotani, R., Sato, M., Okumura, S., & Ishikawa, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094581 · Cited by 81 · cited 3×
“Interestingly, PKA signaling is often related to neuronal survival [5, 12, 16], whereas Epac activation can lead to oxidative stress and neuronal injury [12, 13] (Figure 2).”
Vukičević, S., Šimić, P., Borovečki, F., Grgurević, L., Rogić, D., Orlić, I., GRASSER, W. A., Thompson, D. D., & Paralkar, V. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001715 · Cited by 78
Chun, K., Lao, H.-C., Trempus, C. S., Okada, M., & Langenbach, R. I. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp168 · Cited by 77
Treffkorn, L., Scheibe, R., Maruyama, T., & Dieter, P. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.07.005 · Cited by 73
Stimulation of Prostaglandin EP2 Receptors Prevents NMDA-Induced Excitotoxicity
Ahmad, A. S., Zhuang, H., Echeverría, V., & Doré, S. (2006) · Journal of Neurotrauma · doi:10.1089/neu.2006.23.1895 · Cited by 72
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia
Li, J., Liang, X., Wang, Q., BREYER, R. M., McCullough, L. D., & Andreasson, K. I. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.054 · Cited by 72
Hsiao, H., Mak, O., Yang, C., Liu, Y., Fang, K., & Tzeng, S. (2007) · Glia · doi:10.1002/glia.20453 · Cited by 71
Involvement of Prostaglandin E2 in Production of Amyloid-β Peptides Both in Vitro and in Vivo
Hoshino, T., Nakaya, T., Homan, T., Tanaka, K.-I., Sugimoto, Y., Araki, W., Narita, M., Narumiya, S., Suzuki, T., & Mizushima, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703087200 · Cited by 71
Altered hippocampal long‐term synaptic plasticity in mice deficient in the PGE2 EP2 receptor
Yang, H., Zhang, J., BREYER, R. M., & Chen, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05766.x · Cited by 70 · cited 2×
“Application of PGE2 or butaprost enhances synaptic transmission in wild-type mice, which can be attenuated by PKA inhibitor H-89, suggesting that PGE2 modulates long-term synaptic plasticity and cognitive functions mainly through EP2/Gs/cAMP/PKA/ CREB signaling cascade (Figure 2), although ERK and IP3 pathways might a…”
姚, 成. (2011) · Medical Entomology and Zoology · Cited by 69
Minamizaki, T., Yoshiko, Y., Kozai, K., Aubin, J. E., & Maeda, N. (2009) · Bone · doi:10.1016/j.bone.2009.02.010 · Cited by 69
Chun, K., Lao, H., & Langenbach, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117689 · Cited by 68
Jang, M. W., Yun, S. P., Park, J. H., Ryu, J. M., Lee, J., & Han, H. J. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24084 · Cited by 67
Yun, S. P., Ryu, J. M., Jang, M. W., & Han, H. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22366 · Cited by 67
Savonenko, A., Munoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R. M., Montine, T. J., Kirkwood, A., & Andreasson, K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 66 · cited 1×
“A contribution of EP2 receptor to synaptic plasticity and cognitive functions is further recognized by findings of impaired hippocampal LTP, long-term depression, and cognitive functions in EP2−/− mice [27, 28].”
Jiang, J., Suppiramaniam, V., & Wooten, M. W. (2006) · Neurosignals · doi:10.1159/000105517 · Cited by 66
Self-citationKunori, S., Matsumura, S., Okuda‐Ashitaka, E., Katano, T., Audoly, L., Urade, Y., & Ito, S. (2010) · Glia · doi:10.1002/glia.21090 · Cited by 66 · cited 2×
“As the resident macrophage of the brain, microglia are the major executor of innate immunity in the CNS and their activities are highly regulated by PGE2/EP2 signaling [52, 84-86].”
Tian, M., & Schiemann, W. P. (2009) · The FASEB Journal · doi:10.1096/fj.09-141341 · Cited by 63
Carrasco, E., Werner, P., & Casper, D. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.111 · Cited by 56
EP2receptor mediates PGE2-induced cystogenesis of human renal epithelial cells
Elberg, G., Elberg, D., Lewis, T. V., Guruswamy, S., Chen, L., Logan, C. J., Chan, M. D., & Turman, M. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00036.2007 · Cited by 54
Yuhki, K., Kojima, F., Yamada, T., Fujino, T., Hara, A., Takayama, K., Maruyama, T., Yoshida, A., Narumiya, S., Kuriyama, S., et al. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0043 · Cited by 50
Putative Role of Prostaglandin Receptor in Intracerebral Hemorrhage
Mohan, S., Ahmad, A. S., Glushakov, A. V., Chambers, C., & Doré, S. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00145 · Cited by 47
AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62
Jiang, J., Parameshwaran, K., Seibenhener, M. L., Kang, M., Suppiramaniam, V., Huganir, R. L., Diaz‐Meco, M. T., & Wooten, M. W. (2009) · Hippocampus · doi:10.1002/hipo.20528 · Cited by 46
Self-citationDivergent effects of prostaglandin receptor signaling on neuronal survival
Wu, L., Wang, Q., Liang, X., & Andreasson, K. I. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.055 · Cited by 46 · cited 1×
“EP2 upregulation by LPS contributes to cerebral oxidative damage and secondary neurotoxicity, usually accompanied by induction of NOS and COX activities [81-83].”
Akaneya, Y., & Tsumoto, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3028-06.2006 · Cited by 44
Brouxhon, S. M., Konger, R. L., VanBuskirk, J., Sheu, T.-J., Ryan, J. L., ERDLE, B. J., Almudevar, A., BREYER, R. M., SCOTT, G. A., & Pentland, A. P. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700547 · Cited by 43
Takadera, T., & Ohyashiki, T. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.08.026 · Cited by 43
Pooler, A. M., Arjona, A. A., Lee, R. K. K., & Wurtman, R. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.03.013 · Cited by 42
Keene, C. D., Chang, R. C., Stephen, C., Nivison, M. P., Nutt, S. E., Look, A. E., BREYER, R. M., Horner, P. J., Hevner, R. F., & Montine, T. J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081153 · Cited by 37 · cited 1×
“PGE2 signaling via either EP1 or EP2 leads to TLR4-dependent degeneration of intermediate progenitor cells in the hippocampal subgranular zone [89].”
Chang, S.-H., Liu, C. H., Wu, M.-T., & Hla, T. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.12.001 · Cited by 37 · cited 1×
“PGE2 signaling via EP2 in mammary epithelial cells triggers hyperplasia of mammary glands and regulates VEGF induction in mouse mammary tumor cells [65, 66].”
Banu, S. K., Lee, J., Speights, V. O., Starzinski‐Powitz, A., & Arosh, J. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.94.7.9993 · Cited by 36
Cimino, P. J., Yang, Y., Li, X., Hemingway, J. F., Cherne, M. K., Khademi, S. B., Fukui, Y., Montine, K. S., Montine, T. J., & Keene, C. D. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.01.002 · Cited by 36
Zahner, G., Schaper, M., Panzer, U., Kluger, M. A., Stahl, R. A. K., Thaiss, F., & Schneider, A. (2009) · Biochemical Journal · doi:10.1042/bj20090420 · Cited by 35 · cited 2×
“Other inflammatory mediators regulated by PGE2/EP2 signaling include IL-6 [75, 77, 78, 86], IL-10 [47, 78, 86], IFN-γ [76, 86], TNF-α [47, 75, 77, 78, 86], CCL-2 (MCP-1) [86, 90], and intercellular adhesion molecule-1 (ICAM-1) [91], although the EP4 receptor might also potentially contribute.”
Transcription Factors in the Nervous System: Development, Brain Function, and Diseases
(2005) · Wiley eBooks · doi:10.1002/3527608036 · Cited by 34
Cameron, K. O., Lefker, B. A., Ke, H. Z., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.059 · Cited by 31 · cited 1×
“However, butaprost is only about 18-fold selective for EP2 over EP3 in binding studies [32]; CAY10399 and ONO-AE1-259 are highly EP2 selective but have a prostanoid-like structure; CP-533536 is only about 64-fold selective over the EP4 receptor [33]; compound 9 is quite selective against other PGE2 receptors but less…”
Prostaglandin E2 reduces amyloid β-induced phagocytosis in cultured rat microglia
Nagano, T., Kimura, S. H., & Takemura, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.086 · Cited by 31 · cited 1×
“EP2 receptor activation by PGE2 and butaprost can reduce Aβ-induced phagocytosis in cultured rat microglia [100], identifying microglial EP2 as a possible therapeutic target for AD.”
Mori, A., Ishii, T., Kuroki, T., Shigeta, N., Sakamoto, K., Nakahara, T., & Ishii, K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.051 · Cited by 30
Sakurai, T., Suzuki, K., Yoshie, M., Hashimoto, K., Tachikawa, E., & Tamura, K. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0357 · Cited by 30 · cited 1×
“In addition, PGE2 facilitates tube formation via EP2/PKA signaling in rat luteal endothelial cells, indicating the involvement of EP2 receptor in luteal angiogenesis and progression of ovarian cancer [72].”
Howe, L. R., Subbaramaiah, K., Kent, C. V., Zhou, X. K., Chang, S., Hla, T., Jakobsson, P., Hudis, C. A., & Dannenberg, A. J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.04.002 · Cited by 30
The Role of CREB and CBP in Brain Function
Barco, Á., & Kandel, E. R. (2005) · Wiley eBooks · doi:10.1002/3527608036.ch11 · Cited by 18 · cited 3×
“In response to theta-burst stimulation, Gs-coupled EP2 receptor translocates from cytosol to postsynaptic membrane, while Gi-coupled EP3 receptor moves oppositely, resulting in enhanced postsynaptic cAMP/PKA signaling [22], which in turn activates CREB, a well-documented transcription factor for the late stage of LTP…”
Prostaglandin E2 reduces extracellular ATP-induced migration in cultured rat microglia
Nagano, T., Kimura, S. H., & Takemura, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.018 · Cited by 14 · cited 1×
“As the resident macrophage of the brain, microglia are the major executor of innate immunity in the CNS and their activities are highly regulated by PGE2/EP2 signaling [52, 84-86].”
Hara, S., Kobayashi, M., Kuriiwa, F., Mukai, T., & Mizukami, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.002 · Cited by 12 · cited 3×
“Interestingly, PKA signaling is often related to neuronal survival [5, 12, 16], whereas Epac activation can lead to oxidative stress and neuronal injury [12, 13] (Figure 2).”
Protective Effect of Prostaglandin E2 Receptors EP2 and EP4 in Alloimmune Response In Vivo
Nomi, T., Sho, M., Akahori, T., Kanehiro, H., & Nakajima, Y. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.118 · Cited by 11
Cited by
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 893
Restoring metabolism of myeloid cells reverses cognitive decline in ageing
Minhas, P. S., Latif-Hernandez, A., McReynolds, M. R., Durairaj, A. S., Wang, Q., Rubin, A., Joshi, A. U., He, J. Q., Gauba, E., Liu, L., et al. (2021) · Nature · doi:10.1038/s41586-020-03160-0 · Cited by 526
Inflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409
Astrocytes in the initiation and progression of epilepsy
Vezzani, A., Ravizza, T., Bedner, P., Aronica, E., Steinhäuser, C., & Boison, D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00727-5 · Cited by 272
Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside
Dey, A., Kang, X., Qiu, J., Du, Y., & Jiang, J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.001 · Cited by 215
“Several potent and selective antagonists for EP2 receptor have been developed in the past few years (Figure 2C) [52,55].”
BackgroundSelf-citation
Metadata
- Authors
- Jiang, J., & Dingledine, R.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 34
- Issue
- 7
- Pages
- 413-423
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2059126872
- Cited by
- 166
- References
- 130
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.